Dicolano, Norbea M.
HRN: 23-15-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2023
CEFUROXIME 750MG (VIAL)
06/12/2023
06/19/2023
IV
550mg
Q8
URTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes